Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Respiratory Insufficiency 1Radiation Pneumonitis 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Abnormalities, Radiation-Induced 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Tomography, Emission-Computed, Single-Photon × 1 year × Clear all
NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

University of Wisconsin, Madison

Phase 1 Recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04676828 2026-02-24

ASPECT

University of Aarhus

Phase NA Recruiting
90 enrolled
Thoracic

Abnormalities, Radiation-Induced, Lung Diseases, Lung Neoplasms, Respiratory Insufficiency, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡